S&P 500

5.321,41

0,25%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Adhera Therapeutics Inc (PK) (ATRX)
Adhera Therapeutics Inc (PK) (ATRX) Notícias

ATRX

Adhera Therapeutics (PK) (ATRX)

Adhera Therapeutics Inc (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:ATRX

1

Data	Hora	Fonte	Título	Código	Companhia
30/01/2024	18:00	Edgar (US Regulatory)	Form SEC STAFF ACTION - SEC Staff Action: ORDER	USOTC:ATRX	Adhera Therapeutics Inc (PK)
18/01/2024	18:25	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ATRX	Adhera Therapeutics Inc (PK)
20/11/2023	18:51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ATRX	Adhera Therapeutics Inc (PK)
15/11/2023	18:35	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ATRX	Adhera Therapeutics Inc (PK)
22/05/2023	16:14	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
05/05/2023	17:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
31/03/2023	16:17	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
02/12/2022	19:08	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
18/08/2022	13:48	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
17/06/2022	17:02	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
29/04/2022	17:58	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
21/04/2022	17:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
01/04/2022	17:02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
16/11/2021	18:05	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
11/05/2021	17:22	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
19/02/2020	11:57	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
19/11/2019	19:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
05/11/2019	16:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
31/10/2019	17:58	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
26/09/2019	17:25	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
20/08/2019	18:02	Edgar (US Regulatory)	Tender Offer Statement by Issuer (sc To-i)	USOTC:ATRX	Adhera Therapeutics Inc (PK)
03/05/2019	18:08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:ATRX	Adhera Therapeutics Inc (PK)